Abnormalities in tau protein, synaptic dysfunction, disturbance in the balance of excitatory and inhibitory neuronal circuits, and the presence of amyloid-β plaques contribute to enhanced neuronal hyperactivity observed in AD organoids compared to wild type [202,203]. The gene discussed is MAPT; the disease is Alzheimer disease.